CRISPR Therapeutics AG (CRSP) › Total LiabilitiesCRISPR Therapeutics AG (CRSP) — Total LiabilitiesAnnual figures by fiscal year, from SEC filings.2015: $124.03M2016: $112.12M2017: $83.51M2018: $96.82M2019: $127.33M2020: $163.73M2021: $352.42M2022: $367.58M2023: $346.77M2024: $309.95M2025: $343.43M$343.43M2015Total Liabilities (USD)2025Fiscal YearTotal LiabilitiesChange YoY2025$343.43M+10.8%2024$309.95M-10.6%2023$346.77M-5.7%2022$367.58M+4.3%2021$352.42M+115.2%2020$163.73M+28.6%2019$127.33M+31.5%2018$96.82M+15.9%2017$83.51M-25.5%2016$112.12M-9.6%2015$124.03M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share